Group One Trading
ABEO icon

Group One Trading’s Abeona Therapeutics ABEO Stock Holding History

Group One Trading’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$945K Buy
211,000
+163,400
+343% +$817K ﹤0.01% 2781
2025
Q4 		$251K Sell
47,600
-238,400
-83% -$1.2M ﹤0.01% 4169
2025
Q3 		$1.51M Buy
286,000
+150,700
+111% +$956K ﹤0.01% 2597
2025
Q2 		$769K Buy
135,300
+109,600
+426% +$624K ﹤0.01% 3005
2025
Q1 		$122K Buy
+25,700
New +$140K ﹤0.01% 4437
2024
Q4 		– Sell
-4,000
Closed -$25.3K – 7169
2024
Q3 		$25.3K Buy
4,000
+3,900
+3,900% +$20.4K ﹤0.01% 5109
2024
Q2 		$424 Buy
+100
New +$510 ﹤0.01% 6468
2024
Q1 		– Sell
-3,900
Closed -$19.5K – 6917
2023
Q4 		$19.5K Buy
3,900
+400
+11% +$1.76K ﹤0.01% 5766
2023
Q3 		$14.7K Buy
+3,500
New +$13.2K ﹤0.01% 6111
2021
Q4 		– Sell
-1,828
Closed -$51K – 8099
2021
Q3 		$51K Sell
1,828
-1,664
-48% -$53.3K ﹤0.01% 6525
2021
Q2 		$136K Sell
3,492
-2,708
-44% -$110K ﹤0.01% 5638
2021
Q1 		$291K Buy
6,200
+5,880
+1,838% +$324K ﹤0.01% 4606
2020
Q4 		$13K Sell
320
-124
-28% -$4.22K ﹤0.01% 5684
2020
Q3 		$11K Sell
444
-64
-13% -$4.04K ﹤0.01% 5373
2020
Q2 		$37K Sell
508
-300
-37% -$20.7K ﹤0.01% 4532
2020
Q1 		$42K Sell
808
-96
-11% -$6.41K ﹤0.01% 3812
2019
Q4 		$74K Buy
904
+736
+438% +$51.9K ﹤0.01% 3819
2019
Q3 		$9K Sell
168
-124
-42% -$9.29K ﹤0.01% 4613
2019
Q2 		$35K Sell
292
-292
-50% -$49K ﹤0.01% 3949
2019
Q1 		$107K Sell
584
-56
-9% -$10K ﹤0.01% 3127
2018
Q4 		$114K Sell
640
-232
-27% -$50.6K ﹤0.01% 3094
2018
Q3 		$279K Sell
872
-768
-47% -$272K ﹤0.01% 2763
2018
Q2 		$656K Sell
1,640
-1,196
-42% -$523K 0.01% 2080
2018
Q1 		$1.02M Sell
2,836
-288
-9% -$107K 0.01% 1510
2017
Q4 		$1.24M Buy
3,124
+712
+30% +$294K 0.01% 1545
2017
Q3 		$1.03M Buy
2,412
+2,192
+996% +$589K 0.01% 1548
2017
Q2 		$35K Buy
+220
New +$30K ﹤0.01% 3677
2017
Q1 		– Sell
-40
Closed -$5K – 4564
2016
Q4 		$5K Buy
+40
New +$6.26K ﹤0.01% 4086
2015
Q4 		– Sell
-124
Closed -$13K – 4681
2015
Q3 		$13K Hold
124
– – ﹤0.01% 4196
2015
Q2 		$16K Buy
+124
New +$18.6K ﹤0.01% 4130

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's ABEO Position: Q1 2026 in Review

Group One Trading reduced its Abeona Therapeutics (ABEO) stake by 35% in Q1 2026, selling an estimated $572K and leaving 209,607 shares worth $939K. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

Group One Trading first reported a position in ABEO in Q3 2015 and has held it in 26 quarters since. The position peaked at $1.81M in Q3 2017. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Group One Trading held 209,607 shares of Abeona Therapeutics worth $939K as of Q1 2026.
  • Group One Trading sold 114,379 Abeona Therapeutics shares in Q1 2026, an estimated $572K.
  • Abeona Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2788 holding.
  • Group One Trading first reported a position in Abeona Therapeutics in Q3 2015 and has held it in 26 quarters since.
  • Group One Trading's Abeona Therapeutics position peaked at $1.81M in Q3 2017.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.